HIGHLIGHTS
- who: Charlotte Bernigaud and collaborators from the Parasitology, College of Animal Science and Technology, University of Guangxi, Nanning, China have published the article: Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model, in the Journal: (JOURNAL) of October/12,/2016
- what: The primary endpoint was planned to be evaluated on day 14, because the drugs used in this study have not be proven to have an ovicidal activity; and mites can continue to hatch after the drug administrations. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.